CytoDyn Inc (CYDY)
0.1456
0.00 (0.00%)
USD |
OTCM |
May 10, 15:58
CytoDyn Free Cash Flow (Quarterly): -2.335M for Feb. 29, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -2.335M |
| November 30, 2023 | -2.502M |
| August 31, 2023 | -4.495M |
| May 31, 2023 | -3.412M |
| February 28, 2023 | -6.218M |
| November 30, 2022 | -4.406M |
| August 31, 2022 | -11.07M |
| May 31, 2022 | -6.014M |
| February 28, 2022 | -11.06M |
| November 30, 2021 | -28.90M |
| August 31, 2021 | -31.75M |
| May 31, 2021 | -32.83M |
| February 28, 2021 | -23.67M |
| November 30, 2020 | -20.19M |
| August 31, 2020 | -41.01M |
| May 31, 2020 | -29.32M |
| February 29, 2020 | -17.54M |
| November 30, 2019 | -6.794M |
| August 31, 2019 | -15.20M |
| May 31, 2019 | -9.554M |
| February 28, 2019 | -14.76M |
| November 30, 2018 | -17.22M |
| August 31, 2018 | -8.973M |
| May 31, 2018 | -6.979M |
| February 28, 2018 | -10.03M |
| Date | Value |
|---|---|
| November 30, 2017 | -5.890M |
| August 31, 2017 | -7.000M |
| May 31, 2017 | -7.170M |
| February 28, 2017 | -8.799M |
| November 30, 2016 | -4.510M |
| August 31, 2016 | -6.264M |
| May 31, 2016 | -5.238M |
| February 29, 2016 | -11.06M |
| November 30, 2015 | -3.267M |
| August 31, 2015 | -5.249M |
| May 31, 2015 | -4.253M |
| February 28, 2015 | -2.495M |
| November 30, 2014 | -2.697M |
| August 31, 2014 | -2.590M |
| May 31, 2014 | -1.759M |
| February 28, 2014 | -2.737M |
| November 30, 2013 | -2.103M |
| August 31, 2013 | -0.8071M |
| May 31, 2013 | -0.9969M |
| February 28, 2013 | -1.23M |
| November 30, 2012 | -4.258M |
| August 31, 2012 | -0.4113M |
| May 31, 2012 | -1.506M |
| February 29, 2012 | -1.587M |
| November 30, 2011 | -0.7528M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-41.01M
Minimum
Aug 2020
-2.335M
Maximum
Feb 2024
-15.41M
Average
-11.07M
Median
Free Cash Flow (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |
| Oragenics Inc | -1.102M |